As of September 12, 2026: A major development isn’t yet reflected above. Bayer’s Monsanto unit has proposed a $7.25 billion nationwide class settlement (announced February 17, 2026, covering roughly 65,000 pending claims) that would replace case-by-case litigation with a structured claims program paying eligible claimants over up to 21 years. A Missouri state court judge is holding a final fairness hearing on September 14, 2026, though no immediate ruling is expected. Reported per-person amounts under this framework run lower than this article’s stated $100,000–$175,000 average, with public settlement materials citing figures from roughly $6,000 up to over $165,000 depending on diagnosis and exposure. A June 25, 2026 Supreme Court ruling in Monsanto v. Durnell, finding federal law preempts state failure-to-warn claims, has also narrowed the option of opting out to sue individually.
Last updated: September 2026
The average payout for a Roundup lawsuit in 2026 falls between $100,000 and $175,000 for most settled claims. Some cases have resolved for far less, while others have produced jury verdicts worth millions.
If you used Roundup and developed cancer, this number matters to you. Bayer has now spent over $16 billion resolving Roundup claims since 2020. Yet thousands of cases remain open heading into 2026.
This article breaks down settlement amounts by tier, explains what drives your payout up or down, and covers the latest 2026 updates. You’ll learn who qualifies, how to file, and what you’ll actually take home after fees.
One stat worth knowing right away: the largest single Roundup verdict ever topped $2.25 billion before it was reduced on appeal.
What Is the Average Payout for a Roundup Lawsuit
The average payout for a Roundup lawsuit sits in the range of $100,000 to $175,000 based on settled individual claims through the Bayer resolution programs. This figure represents the middle ground across thousands of resolved cases.
That said, “average” can be misleading here. Roundup payouts aren’t one-size-fits-all. They swing wildly based on cancer type, treatment severity, and how strong your evidence is.
Think of it like car insurance claims. A fender bender pays out very differently than a totaled vehicle. Roundup settlements work the same way. A claimant with Stage IV non-Hodgkin lymphoma and decades of heavy Roundup use will receive far more than someone with a milder diagnosis.
| Payout Category | Estimated Range |
|---|---|
| Low-tier settlements | $5,000 to $50,000 |
| Mid-tier settlements | $50,000 to $175,000 |
| High-tier settlements | $175,000 to $500,000 |
| Exceptional cases | $500,000 to $5,000,000+ |
Trial verdicts have produced amounts far above these ranges. But most people settle before trial because of the time and risk involved.
The real question isn’t just what the average is. It’s where your case falls on this spectrum.
Roundup Lawsuit Settlement Amounts by Tier
Roundup lawsuit settlement amounts are organized into tiers based on injury severity and evidence strength. Bayer’s global settlement program uses a point-based system to rank claims and assign dollar values.
Tier 1 cases involve claimants with aggressive forms of non-Hodgkin lymphoma, long exposure histories, and strong medical records. These cases settle between $175,000 and $500,000 or more.

Tier 2 cases cover mid-range claims. These claimants typically have confirmed NHL but shorter exposure periods or less documentation. Settlement amounts here run from $50,000 to $175,000.
Tier 3 captures lower-value claims. These might involve limited exposure, weaker causation evidence, or cancers that are harder to link directly to glyphosate. Payouts in this tier range from $5,000 to $50,000.
| Tier | Cancer Severity | Exposure Evidence | Settlement Range |
|---|---|---|---|
| Tier 1 | Severe/fatal NHL | Strong, long-term | $175,000 to $500,000+ |
| Tier 2 | Confirmed NHL | Moderate | $50,000 to $175,000 |
| Tier 3 | Mild or uncertain | Limited | $5,000 to $50,000 |
These tiers aren’t published by Bayer officially. They come from analysis of resolved cases and reporting by legal industry sources.
Your tier placement depends heavily on your medical records and how well your attorney builds your claim.
Roundup Lawsuit Payout Per Person
The Roundup lawsuit payout per person varies significantly, but the median individual payout for settled claims has been roughly $120,000 to $150,000. This figure reflects what a typical claimant with a solid case actually receives before attorney fees.
Per-person payouts differ from total settlement numbers you see in headlines. When reports say Bayer set aside $10.9 billion in 2020, that pool covered roughly 100,000 claims. Simple math gives you about $109,000 per claim on average.
But not every claim is created equal. A claimant who died from diffuse large B-cell lymphoma after 20 years of occupational Roundup use received substantially more than someone with limited residential exposure.
- Occupational users (farmers, landscapers, groundskeepers) tend to receive higher payouts
- Residential users receive lower amounts on average
- Deceased claimants’ families often receive larger settlements due to wrongful death claims
- Claimants with multiple rounds of chemotherapy document higher damages
Per-person payouts also depend on when you filed. Earlier filers in the MDL often secured better terms. Cases filed in 2025 and 2026 may face different settlement dynamics as Bayer works to finalize its remaining exposure.
Key Takeaway: The average Roundup payout per person ranges from $100,000 to $175,000, but your specific amount depends on cancer severity, exposure history, and the strength of your documentation.
How Roundup Lawsuit Payouts Are Calculated
Roundup lawsuit payouts are calculated using a points-based system that weighs several medical and legal factors. The more points your claim scores, the higher your settlement offer.
Bayer and the court-appointed settlement administrators evaluate each claim against a set of criteria. This isn’t random. It’s systematic and data-driven.
Here are the primary factors in the calculation:
- Cancer diagnosis: Specific type of NHL and its aggressiveness
- Exposure duration: How many years you used Roundup products
- Exposure frequency: How often you applied the product (daily, weekly, seasonal)
- Medical treatment: Chemotherapy, radiation, bone marrow transplants, hospitalizations
- Age at diagnosis: Younger claimants with long life expectancy impacts may score higher
- Death: Wrongful death claims carry additional weight
| Factor | Impact on Payout |
|---|---|
| Aggressive NHL subtype | High increase |
| 10+ years of regular use | Significant increase |
| Multiple chemo rounds | Moderate increase |
| Wrongful death | Major increase |
| Residential-only use | Moderate decrease |
| Weak medical documentation | Significant decrease |
The system works like a scoring rubric. Each factor adds or subtracts points. Your total score determines which settlement tier you fall into.
Strong medical records and purchase documentation make a measurable difference. Claimants who kept receipts, employment records, or photos of Roundup use have stronger claims.
What Determines Your Roundup Lawsuit Payout
Your Roundup lawsuit payout is determined by the unique facts of your case, not by a flat rate applied to all claimants. Two people with the same cancer can receive very different amounts.
The single biggest factor is your diagnosis. Non-Hodgkin lymphoma has several subtypes, and some are more commonly linked to glyphosate exposure than others.
Diffuse large B-cell lymphoma (DLBCL) is the most frequently cited subtype in Roundup cases. Follicular lymphoma and chronic lymphocytic leukemia also appear in claims.
Beyond diagnosis, these details shape your payout:
- Whether your cancer went into remission or progressed
- Your total medical expenses, including future projected costs
- Lost wages and earning capacity
- Pain, suffering, and diminished quality of life
- Whether you can prove you specifically used Roundup brand products
Another underrated factor is your jurisdiction. Cases filed in plaintiff-friendly states like California have historically produced larger verdicts. Cases in more conservative courts may settle for less.
Your attorney’s experience with Roundup litigation matters too. Firms handling hundreds of Roundup cases have better data on settlement ranges and stronger negotiating positions.
Roundup Lawsuit Settlement Amount Ranges
Roundup lawsuit settlement amounts range from $5,000 for the weakest claims to over $5 million for the most severe cases. Most settlements cluster between $100,000 and $250,000.
This wide range reflects the diversity of claimants. A retired landscaper with Stage IV lymphoma has a radically different case than someone who sprayed Roundup on their driveway twice a year.
| Claim Strength | Settlement Range | Typical Claimant Profile |
|---|---|---|
| Very Strong | $500,000 to $5M+ | Fatal NHL, decades of heavy use, strong records |
| Strong | $175,000 to $500,000 | Aggressive NHL, years of regular use |
| Moderate | $50,000 to $175,000 | Confirmed NHL, moderate exposure |
| Weak | $5,000 to $50,000 | Limited exposure, weak documentation |
Some cases fall outside these ranges entirely. The three bellwether trial verdicts produced awards of $289 million, $80 million, and $2.25 billion before post-trial reductions.
Most claimants never go to trial. Roughly 95% of Roundup cases settle through negotiation or the structured resolution programs. Trial is expensive, slow, and risky for both sides.
If you’re trying to estimate your potential amount, focus on the settlement ranges above. Trial verdicts grab headlines, but settlements pay the bills for most claimants.
Key Takeaway: Settlement amounts range from $5,000 to over $5 million, with most resolved claims falling between $100,000 and $250,000 depending on case strength.
Overview of Roundup Lawsuit Settlements
Roundup lawsuit settlements represent one of the largest mass tort resolutions in American legal history. Bayer has committed more than $16 billion to resolving Roundup-related cancer claims since acquiring Monsanto in 2018.
The settlement wave began in June 2020 when Bayer announced a $10.9 billion deal to resolve approximately 100,000 pending claims. That initial fund covered cases filed through the multidistrict litigation (MDL 2741) in the Northern District of California.
Since then, Bayer has added billions more to cover claims filed after the 2020 announcement. The company set aside an additional $4.5 billion in 2022 to handle future claims.
Here’s a simplified timeline of the settlement history:
| Year | Development |
|---|---|
| 2018 | Bayer acquires Monsanto for $63 billion |
| 2018 | First Roundup verdict (Johnson v. Monsanto, $289M) |
| 2019 | Hardeman verdict ($80M), Pilliod verdict ($2.25B) |
| 2020 | Bayer announces $10.9 billion settlement |
| 2021-2023 | Individual claim resolutions begin |
| 2024 | Supreme Court declines Bayer’s appeal |
| 2025 | Continued settlements, new filings accepted |
| 2026 | Remaining claims processed, new filing window narrows |
The settlements are not a single class action payout. Each claim is resolved individually based on its own merits. This distinction matters because it means your settlement is negotiated based on your specific case facts.
How the Roundup Lawsuit Settlement Process Works
The Roundup lawsuit settlement process works through individual claim evaluation, not a single lump-sum class action distribution. Each claimant’s case is reviewed, scored, and offered a settlement amount based on its merits.
Here’s how the process typically unfolds:
- Filing: You or your attorney file your claim with supporting medical and exposure documentation
- Review: Settlement administrators evaluate your claim against scoring criteria
- Offer: You receive a settlement offer based on your tier placement
- Negotiation: Your attorney may negotiate for a higher amount
- Acceptance: You accept or reject the offer
- Payment: Funds are distributed, typically within 60 to 90 days of acceptance
The timeline from filing to payment has varied widely. Some claimants who filed early received checks within 12 to 18 months. Others have waited three years or longer.
One common misconception is that this is a class action. It’s not. Roundup litigation is a mass tort handled through multidistrict litigation (MDL). The difference is significant. In a class action, everyone gets the same payout. In a mass tort, each person’s case stands on its own.
- You need your own attorney representing your individual claim
- Your settlement is based on your medical records, not a group average
- You can reject a settlement offer and choose to go to trial
This individual approach means more work, but it also means your payout reflects your actual damages.
Roundup Lawsuit Settlement Update for 2026
The Roundup lawsuit settlement update for 2026 shows Bayer continuing to resolve remaining claims while facing pressure from newly filed cases. As of early 2026, Bayer has resolved the majority of its original 100,000-claim backlog, but tens of thousands of cases remain active.
Several key developments define the 2026 landscape:
- Bayer’s ongoing financial exposure: The company has disclosed plans to manage Roundup liabilities through 2028
- New filings: Claimants continue to file new cases, particularly those recently diagnosed with NHL
- Statute of limitations pressure: Many states have filing deadlines that could expire for people diagnosed years ago
- No global settlement for future claims: Bayer’s attempt to create a class-wide resolution for future claimants was rejected by courts
| 2026 Update | Status |
|---|---|
| Original settlement fund | Mostly distributed |
| New claims being accepted | Yes, through individual filings |
| Supreme Court intervention | No new petitions pending |
| Average processing time | 12 to 24 months from filing |
| Bayer’s total spent | Over $16 billion to date |
The 2024 Supreme Court decision not to hear Bayer’s appeal was a turning point. It confirmed that state-level failure-to-warn claims can proceed, keeping the door open for new lawsuits.
For claimants in 2026, the message is clear: cases are still being resolved, but the window for new filings may be narrowing depending on your state’s statute of limitations.
Key Takeaway: Bayer continues settling Roundup claims in 2026, but new filers should act quickly because statute of limitations deadlines vary by state and could expire soon.
Roundup Cancer Lawsuit Settlements Explained
Roundup cancer lawsuit settlements specifically involve claims that glyphosate, the active ingredient in Roundup, caused non-Hodgkin lymphoma or related blood cancers. The cancer connection is the foundation of every Roundup claim.
The link between Roundup and cancer became headline news in 2015. That year, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.”
Monsanto, which developed Roundup, disputed the IARC classification. The EPA has maintained that glyphosate is “not likely to be carcinogenic.” This disagreement has been central to the litigation.
Despite the EPA’s position, juries have repeatedly sided with plaintiffs. The scientific evidence presented at trial included:
- Epidemiological studies linking glyphosate exposure to increased NHL risk
- Internal Monsanto documents suggesting the company knew about cancer risks
- Evidence that Monsanto ghostwrote scientific studies defending glyphosate safety
- Testimony from oncologists connecting specific patients’ cancers to Roundup use
The cancers most commonly involved in settlements include:
| Cancer Type | Frequency in Claims |
|---|---|
| Diffuse large B-cell lymphoma | Most common |
| Follicular lymphoma | Common |
| Chronic lymphocytic leukemia | Moderate |
| Mantle cell lymphoma | Less common |
| Other NHL subtypes | Occasional |
If you were diagnosed with any form of NHL after regular Roundup exposure, your claim falls into this category. The strength of your cancer claim depends on your medical records and the timeline between exposure and diagnosis.
Bayer Roundup Settlement Fund Details
The Bayer Roundup settlement fund totals over $16 billion committed across multiple resolution programs since 2020. This makes it one of the largest product liability settlement funds in history.
Bayer structured its settlement approach in phases. The initial $10.9 billion fund announced in June 2020 targeted the roughly 100,000 claims pending at that time. A separate $2 billion provision was set aside for potential future claims from users not yet diagnosed.
In 2022, Bayer added approximately $4.5 billion to its reserves after courts rejected its proposed class-wide settlement for future claimants. The company has repeatedly adjusted its financial projections upward as new cases continue to be filed.
| Fund Component | Amount | Purpose |
|---|---|---|
| Initial settlement (2020) | $10.9 billion | Resolve ~100,000 pending claims |
| Future claims reserve | $2 billion | Cover newly diagnosed claimants |
| Additional reserves (2022+) | $4.5 billion+ | Handle ongoing and new filings |
| Total committed | $16+ billion | All Roundup-related resolutions |
To put $16 billion in perspective, it exceeds the total GDP of some small countries. It’s roughly what Americans spend on pet food in a single year. Bayer’s Roundup liability has fundamentally reshaped the company’s financial outlook.
The settlement fund is managed by court-appointed administrators and third-party claims processors. Claimants don’t interact with Bayer directly. Everything flows through legal intermediaries.
Bayer has also discontinued glyphosate-based Roundup for the U.S. residential market as of 2023, switching to alternative active ingredients. The commercial and agricultural versions remain available.
Roundup Verdict History and Key Trial Outcomes
Roundup verdict history includes three landmark trials that produced massive jury awards and set the tone for all subsequent settlement negotiations. These verdicts proved that juries were willing to hold Bayer/Monsanto accountable.
Johnson v. Monsanto (August 2018)
Dewayne Johnson, a school groundskeeper with terminal NHL, became the first person to take Monsanto to trial. The jury awarded $289 million in damages. A judge later reduced this to $78.5 million. The case was settled confidentially while on appeal.
Hardeman v. Monsanto (March 2019)
Edwin Hardeman, a homeowner who used Roundup on his property for 26 years, won an $80 million verdict. This was the first federal bellwether trial in the MDL. The Ninth Circuit upheld a reduced award of $25 million.
Pilliod v. Monsanto (May 2019)
Married couple Alva and Alberta Pilliod, both diagnosed with NHL, won a $2.25 billion verdict. This was the largest Roundup award ever. A judge reduced it to $86.7 million.
| Trial | Plaintiff | Original Verdict | Final/Reduced Amount |
|---|---|---|---|
| Johnson v. Monsanto | Dewayne Johnson | $289 million | $78.5 million (then settled) |
| Hardeman v. Monsanto | Edwin Hardeman | $80 million | $25 million |
| Pilliod v. Monsanto | Alva and Alberta Pilliod | $2.25 billion | $86.7 million |
These verdicts matter because they established the legal template for Roundup cases. They proved three things: juries believe glyphosate causes cancer, Monsanto acted with reckless disregard, and punitive damages are appropriate.
Every settlement negotiation since these trials has been shaped by the threat of similar outcomes. Bayer’s willingness to pay billions in settlements stems directly from these courtroom losses.
Key Takeaway: Three landmark jury verdicts totaling over $2.6 billion (before reductions) forced Bayer to commit $16 billion to Roundup settlements and demonstrated that juries hold the company responsible for cancer caused by glyphosate.
Roundup Lawsuit Payouts After Attorney Fees
Roundup lawsuit payouts after attorney fees are typically 60% to 67% of the gross settlement amount. Most Roundup attorneys work on contingency, taking 33% to 40% of the final recovery.
This means if your case settles for $150,000, your attorney takes between $49,500 and $60,000. You receive $90,000 to $100,500 before other deductions.
But attorney fees aren’t the only cost. Additional deductions can include:
- Litigation expenses: Court filing fees, expert witness costs, medical record retrieval ($2,000 to $15,000)
- Medical liens: If health insurance or Medicare paid for your cancer treatment, they may have a right to recover from your settlement
- Case costs: Deposition fees, travel expenses, administrative costs
| Deduction Type | Typical Amount |
|---|---|
| Attorney contingency fee | 33% to 40% of settlement |
| Litigation costs | $2,000 to $15,000 |
| Medical liens | Varies widely |
| Net to claimant | Roughly 55% to 65% of gross |
Here’s a real-world example:
Gross settlement: $200,000
- Attorney fee (33%): $66,000
- Litigation costs: $8,000
- Medical lien: $12,000
- Net payout to you: $114,000
That’s a significant haircut, but it’s standard in contingency-based personal injury cases. You paid nothing upfront, and your attorney took all the financial risk.
Some firms charge higher percentages if the case goes to trial (typically 40%). Ask about fee structures before signing a retainer agreement.
Roundup Lawsuit Timeline for 2026
The Roundup lawsuit timeline for 2026 centers on the resolution of remaining pending claims and the processing of newly filed cases. Most of the original MDL claims have been resolved, but the litigation is not over.
Here’s what the 2026 timeline looks like:
| Phase | Timeline | Details |
|---|---|---|
| New claim filing | Ongoing | Cases still accepted if within statute of limitations |
| Claim review | 3 to 6 months after filing | Documentation evaluated and scored |
| Settlement offer | 6 to 12 months after filing | Based on tier placement |
| Negotiation | 1 to 3 months | Attorney may push for higher amount |
| Payment | 60 to 90 days after acceptance | Check issued to attorney trust account |
| Total from filing to payment | 12 to 24 months typical | Can be faster or slower |
The statute of limitations is the most pressing timeline concern in 2026. Each state sets its own deadline for filing personal injury claims, typically two to three years from the date of diagnosis or the date you reasonably should have known Roundup caused your cancer.
- California: 2 years from discovery
- Texas: 2 years from injury
- Florida: 4 years (recently reduced to 2 years for some claims)
- New York: 3 years from discovery
- Illinois: 2 years from discovery
If you were diagnosed with NHL in 2023 or 2024, your window to file may be closing in 2026. Waiting too long could mean losing your right to compensation entirely.
Who Qualifies for a Roundup Lawsuit
You qualify for a Roundup lawsuit if you were exposed to Roundup or other glyphosate-based herbicides and subsequently diagnosed with non-Hodgkin lymphoma or a related cancer. Both occupational and residential users may be eligible.
The basic eligibility requirements are:
- Exposure: You used or were regularly exposed to Roundup products
- Diagnosis: You developed NHL, CLL, DLBCL, follicular lymphoma, or another linked cancer
- Timing: Your diagnosis came after a period of Roundup exposure
- Statute of limitations: You’re filing within your state’s legal deadline
| Qualifying Factor | Details |
|---|---|
| Required diagnosis | Non-Hodgkin lymphoma or related blood cancer |
| Exposure type | Personal use, occupational, or bystander exposure |
| Minimum exposure | Regular use over at least 1 year (stronger claims: 5+ years) |
| Filing deadline | Varies by state, typically 2 to 4 years from diagnosis |
Not everyone who used Roundup qualifies. You need a cancer diagnosis specifically linked to glyphosate exposure. Using Roundup a few times without developing cancer does not create a viable claim.
The strongest candidates include:
- Farmers and agricultural workers who mixed and applied Roundup regularly
- Landscapers and groundskeepers with years of occupational exposure
- Homeowners who used Roundup weekly or seasonally over many years
- Family members of heavy users who had secondhand exposure
People diagnosed with cancers other than NHL generally don’t qualify under current Roundup litigation. The scientific evidence and legal precedent focus almost exclusively on non-Hodgkin lymphoma and its subtypes.
Key Takeaway: You qualify for a Roundup lawsuit if you have a non-Hodgkin lymphoma diagnosis and a documented history of Roundup exposure, but you must file within your state’s statute of limitations.
How to File a Roundup Lawsuit in 2026
To file a Roundup lawsuit in 2026, you need to contact an attorney experienced in Roundup/glyphosate litigation, provide your medical records and exposure history, and have your claim filed in the appropriate court. The process is still open for new claimants.
Here’s the step-by-step filing process:
Step 1: Gather your documentation
Collect medical records showing your NHL diagnosis, treatment history, and any records of Roundup purchases or use. Employment records are especially valuable for occupational exposure claims.
Step 2: Consult a Roundup attorney
Find a law firm handling Roundup mass tort cases. Most offer free case evaluations. Verify they work on contingency (no upfront costs to you).
Step 3: Case evaluation
Your attorney reviews your medical and exposure history to determine claim strength. This typically takes one to two weeks.
Step 4: Filing
Your attorney files your individual lawsuit, either in the MDL or in state court depending on your situation.
Step 5: Claim processing
Your case enters the settlement evaluation pipeline. Documentation is submitted, reviewed, and scored.
Step 6: Resolution
You receive a settlement offer, negotiate if needed, and accept or reject the terms.
| Filing Checklist | Status |
|---|---|
| NHL diagnosis confirmed | Required |
| Medical records gathered | Required |
| Exposure history documented | Required |
| Attorney retained | Required |
| Statute of limitations checked | Required |
| Claim filed | Your attorney handles this |
Don’t wait to start this process. The statute of limitations is the biggest obstacle for new filers in 2026. Once your deadline passes, no amount of evidence can revive your claim.
Frequently Asked Questions
How much is the average Roundup lawsuit payout in 2026?
The average Roundup lawsuit payout in 2026 is between $100,000 and $175,000 for most settled claims.
Amounts vary based on cancer type, exposure duration, and evidence quality.
Some cases settle for as little as $5,000 while others exceed $1 million.
Has Bayer settled all Roundup lawsuits yet?
No, Bayer has not settled all Roundup lawsuits as of 2026.
The company has resolved the majority of its original 100,000-claim backlog.
Tens of thousands of cases remain pending, and new claims continue to be filed.
Do I qualify for a Roundup lawsuit if I used Roundup at home?
Yes, residential Roundup users can qualify if they developed non-Hodgkin lymphoma after regular use.
Homeowners with years of consistent use have filed successful claims.
Your payout may be lower than occupational users, but you may still be eligible.
How long does it take to get a Roundup settlement check?
Most claimants receive their settlement check within 12 to 24 months from the date of filing.
Some cases resolve faster, while complex cases can take longer.
Payment is issued within 60 to 90 days after you accept a settlement offer.
Will Roundup settlement money be taxed?
Settlement money for physical injuries and sickness is generally not taxed under federal tax law.
Punitive damages and interest on settlements are typically taxable.
Consult a tax professional to understand how your specific settlement will be treated.
What to Do Now
Roundup settlements in 2026 remain available, but the clock is ticking. If you used Roundup and were diagnosed with non-Hodgkin lymphoma, your case could be worth six figures.
Start gathering your medical records and exposure history today. Reach out to an experienced Roundup attorney for a free case evaluation.
The filing window won’t stay open forever. Acting now gives you the best chance at the compensation you deserve.









